4.7 Article

Tuning the Selectivity of Biodegradable Antimicrobial Cationic Polycarbonates by Exchanging the Counter-Anion

Journal

MACROMOLECULAR BIOSCIENCE
Volume 16, Issue 9, Pages 1360-1367

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/mabi.201600090

Keywords

anion exchange; antimicrobial; organocatalysis; polycarbonates; selective

Funding

  1. European Commission [Renaissance-ITN 289347, SUSPOL-EJD 642671]
  2. MINECO through project SUSPOL
  3. FDI [16507]
  4. Institute of Bioengineering and Nanotechnology (Biomedical Research Council)
  5. Institute of Bioengineering and Nanotechnology (Joint Council Office, Agency for Science, Technology and Research, Singapore)
  6. Convocatoria de Contratacion para la especializacion de personal investigador doctor en la UPV/EHU

Ask authors/readers for more resources

There is a growing interest in modern healthcare to develop systems able to fight antibiotic resistant bacteria. Antimicrobial cationic biodegradable polymers able to mimic antimicrobial peptides have shown to be effective against both Gram-positive and Gram-negative bacteria. In these systems, the hydrophilic-hydrophobic ratio and the cationic charge density play a pivotal role in defining the killing efficiency. Nevertheless, many of these antimicrobial polymers show relatively low selectivity as defined by the relative toxicity to mammalian cells or hemolysis relative to pathogens. In this study, a series of polycarbonates containing pendant quaternary ammoniums are used to understand the role of different counter-anions including chloride, citrate, malonate, benzoate, acetate, lactate and trifluoroacetate, and the antibiotic penicillin on antimicrobial efficacy and selectivity. Interestingly, it is found that in spite of the strong antimicrobial activity of trifluoroacetate and benzoate anions, they prove to be much less hemolytic than chloride anion. It is believed that the proper selection of the anion could enhance the potential of antimicrobial polymers to fight against clinically relevant pathogenic infections, while concurrently mitigating harmful side effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available